Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil + tamsulosin for persistent irritative urinary symptoms in men
2010-022138-10Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Micturition disorder and overactive bladder (OAB) comparing Vardenafil + tamsulosin with Placebo control (2 arms). Primary endpoints: Improvement of LUTS diary items and Improvement of International Prostate Symptom Score. Started Jun 2011; status: active.
02
Drugs
vardenafiltamsulosin
03
Conditions
Micturition disorderoveractive bladder (OAB)
Beyond the preview
Go deeper on 2010-022138-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022138-10.